Start for free
Start for free
Morningside Venture Investments logo

Morningside Venture Investments

Asia, Shanghai, China, Shanghai

Description

Morningside Venture Investments is an investment group that provides industry investments and social responsibility.

Investor Profile

Morningside Venture Investments has made 76 investments, with 6 in the past 12 months and 47% as lead.

Stage Focus

  • Series B (33%)
  • Series A (32%)
  • Series C (16%)
  • Seed (7%)
  • Series Unknown (4%)
  • Post Ipo Equity (3%)
  • Series D (3%)
  • Series E (3%)
  • Private Equity (1%)

Country Focus

  • United States (74%)
  • United Kingdom (11%)
  • China (5%)
  • France (4%)
  • Switzerland (3%)
  • The Netherlands (1%)
  • Israel (1%)
  • Australia (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Software
  • Information Technology
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Morningside Venture Investments frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Sectoral Asset Management
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 3
LabCorp
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Tamarisc Ventures
Tamarisc Ventures
North America, California, United States, Irvine
Co-Investments: 4
Cultivation Capital
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 2
Andera Partners
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Bpifrance
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 3
University Ventures
University Ventures
North America, New York, United States, New York
Co-Investments: 3
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

Which angels does Morningside Venture Investments often collaborate with?

JG
Jamie Gates
North America, California, United States, San Francisco
Shared Deals: 1
MA
Shared Deals: 1
NN
Nicholas Negroponte
North America, Massachusetts, United States, Boston
Shared Deals: 1
PT
Peter Thiel
North America, California, United States, San Francisco
Shared Deals: 1
AS
Shared Deals: 1
BT
Belinda Termeer
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
BJ
Benjamin Jealous
North America, Maryland, United States, Baltimore
Shared Deals: 1
EW
Eric Wu
North America, California, United States, San Francisco
Shared Deals: 1
KW
Kelly Wearstler
North America, South Carolina, United States, Myrtle Beach
Shared Deals: 1
JM
Jonathan Milner
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Morningside Venture Investments?

Xealth

Seattle, Washington, United States

Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.

AnalyticsData IntegrationHealth CareInformation TechnologyTherapeutics
Series UnknownMar 25, 2025
SimpliFed

Ithaca, New York, United States

SimpliFed is a telehealth company that provides access to virtual breastfeeding support to new and pregnant parents.

ConsultingHealth CareParentingTelehealth
SeedFeb 4, 2025
Amount Raised: $4,000,000
AdvanCell

Sydney, New South Wales, Australia

AdvanCell is a clinical-stage radiopharmaceutical company that develops novel cancer therapeutics.

BiotechnologyClinical TrialsOncologyPharmaceutical
Series CFeb 3, 2025
Amount Raised: $112,000,000
Geneoscopy

Saint Louis, Missouri, United States

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJan 8, 2025
Amount Raised: $105,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
CairnSurgical

Lebanon, New Hampshire, United States

CairnSurgical is developing innovative patient-specific tools to guide surgical interventions for patients with cancer.

Health CareMedical Device
Series AAug 21, 2024
Amount Raised: $4,500,000
ENYO Pharma

Lyon, Rhone-Alpes, France

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

BiopharmaBiotechnologyMedical
Series CJan 3, 2024
Amount Raised: $42,610,610
Epigenic Therapeutics

Shanghai, Shanghai, China

Epigenic Therapeutics is a biotech firm that offers gene editing therapy.

Biotechnology
Series AAug 29, 2023
Amount Raised: $32,000,000
GaeaStar

San Francisco, California, United States

GaeaStar develops manufacturing and engineering solutions for geo-neutral vessels.

Environmental EngineeringGreenTechManufacturingSustainability
SeedApr 6, 2023
Amount Raised: $6,500,000
Cognito Therapeutics

Cambridge, Massachusetts, United States

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.

BiotechnologyHealth CareHealth DiagnosticsMedical DeviceTherapeutics
Series BMar 22, 2023
Amount Raised: $73,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator